RT Journal Article
SR Electronic
T1 Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 36
OP 40
DO 10.3899/jrheum.200125
VO 96
A1 Lourdes M. Perez-Chada
A1 Joseph F. Merola
A1 April W. Armstrong
A1 Alice B. Gottlieb
YR 2020
UL http://www.jrheum.org/content/96/36.abstract
AB The International Dermatology Outcome Measures (IDEOM) initiative is a nonprofit organization dedicated to enhancing clinical care and research in dermatology by developing evidence-based, patient-centered outcome measures. At the 2019 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the IDEOM psoriasis working group presented an overview of its selected deliverables and discussed its efforts to agree on meaningful, valid, and feasible outcome measures for quality measurement in psoriasis. The psoriatic arthritis (PsA) workgroup focused on the measurement of PsA symptoms in psoriasis clinical trials, and the measurement of nonspecific musculoskeletal symptoms among patients with psoriasis in psoriasis longitudinal clinical trials and cohort studies.